Cargando…

Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer’s disease

Network-sensitive neuroimaging methods have been used to characterize large-scale brain network degeneration in Alzheimer’s disease and its prodrome. However, few studies have investigated the combined effect of Alzheimer’s disease and cerebrovascular disease on brain network degeneration. Our study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chong, Joanna Su Xian, Liu, Siwei, Loke, Yng Miin, Hilal, Saima, Ikram, Mohammad Kamran, Xu, Xin, Tan, Boon Yeow, Venketasubramanian, Narayanaswamy, Chen, Christopher Li-Hsian, Zhou, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841199/ https://www.ncbi.nlm.nih.gov/pubmed/29053778 http://dx.doi.org/10.1093/brain/awx224

Ejemplares similares

Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer’s disease
por: Vipin, Ashwati, et al.
Publicado: (2018)

Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer’s disease with and without cerebrovascular disease
por: Ji, Fang, et al.
Publicado: (2017)

Inter-hemispheric functional dysconnectivity mediates the association of corpus callosum degeneration with memory impairment in AD and amnestic MCI
por: Qiu, Yingwei, et al.
Publicado: (2016)

White matter microstructural abnormalities and default network degeneration are associated with early memory deficit in Alzheimer’s disease continuum
por: Ji, Fang, et al.
Publicado: (2019)

Distinct BOLD variability changes in the default mode and salience networks in Alzheimer’s disease spectrum and associations with cognitive decline
por: Zhang, Liwen, et al.
Publicado: (2020)

The Diagnostic Utility of the NINDS-CSN Neuropsychological Battery in Memory Clinics
por: Xu, Xin, et al.
Publicado: (2016)

Additive effect of cerebral atrophy on cognition in dementia-free elderly with cerebrovascular disease
por: Xu, Xin, et al.
Publicado: (2019)

Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease
por: Zhu, Yanan, et al.
Publicado: (2017)

Age-Related Eye Diseases in Individuals With Mild Cognitive Impairment and Alzheimer's Disease
por: Chua, Jacqueline, et al.
Publicado: (2022)

Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
por: Chai, Yuek Ling, et al.
Publicado: (2021)

Beyond Screening: Can the Mini-Mental State Examination be Used as an Exclusion Tool in a Memory Clinic?
por: Xu, Xin, et al.
Publicado: (2015)

The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
por: Chen, Christopher L.H., et al.
Publicado: (2019)

Impact of Strategically Located White Matter Hyperintensities on Cognition in Memory Clinic Patients with Small Vessel Disease
por: Biesbroek, J. Matthijs, et al.
Publicado: (2016)

Serum Hepatocyte Growth Factor Is Associated with Small Vessel Disease in Alzheimer’s Dementia
por: Zhu, Yanan, et al.
Publicado: (2018)

Markers of Cardiac Dysfunction in Cognitive Impairment and Dementia
por: Hilal, Saima, et al.
Publicado: (2015)

Retinal microvasculature dysfunction is associated with Alzheimer’s disease and mild cognitive impairment
por: Chua, Jacqueline, et al.
Publicado: (2020)

Alterations in Brain Network Topology and Structural-Functional Connectome Coupling Relate to Cognitive Impairment
por: Wang, Juan, et al.
Publicado: (2018)

Inflammaging as a prodrome to Alzheimer's disease
por: Giunta, Brian, et al.
Publicado: (2008)

Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?
por: Dommershuijsen, Lisanne J., et al.
Publicado: (2020)

Amyloid imaging in prodromal Alzheimer's disease
por: Ossenkoppele, Rik, et al.
Publicado: (2011)

Retinal Vascular Fractals and Cognitive Impairment
por: Ong, Yi-Ting, et al.
Publicado: (2014)

Brainstem substructures and cognition in prodromal Alzheimer’s disease
por: Dutt, Shubir, et al.
Publicado: (2021)

Risk Factors and Consequences of Cortical Thickness in an Asian Population
por: Hilal, Saima, et al.
Publicado: (2015)

Cortical microinfarcts in memory clinic patients are associated with reduced cerebral perfusion
por: Ferro, Doeschka A, et al.
Publicado: (2019)

Cerebral Small Vessel Disease and Enlarged Perivascular Spaces-Data From Memory Clinic and Population-Based Settings
por: Gyanwali, Bibek, et al.
Publicado: (2019)

Telomere Length and the Risk of Alzheimer’s Disease: The Rotterdam Study
por: Fani, Lana, et al.
Publicado: (2020)

Involvement of mirror neuron system in prodromal Alzheimer's disease
por: Moretti, D.V.
Publicado: (2016)

Targeting prodromal Alzheimer’s disease: too late for prevention?
por: Yassine, Hussein N
Publicado: (2017)

Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer’s disease
por: Nakamura, Akinori, et al.
Publicado: (2018)

Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease
por: Nielsen, Rune B., et al.
Publicado: (2020)

A Case of Minimally Progressive Prodromal Alzheimer’s Disease
por: Rosenbloom, Michael H., et al.
Publicado: (2023)

Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease
por: Guieysse, Thomas, et al.
Publicado: (2023)

Advances in Neurological Diseases and Stroke
por: Venketasubramanian, Narayanaswamy
Publicado: (2023)

A multi-regression framework to improve diagnostic ability of optical coherence tomography retinal biomarkers to discriminate mild cognitive impairment and Alzheimer’s disease
por: Chua, Jacqueline, et al.
Publicado: (2022)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021)

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
por: Blennow, Kaj, et al.
Publicado: (2010)

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Utility of the NIH Toolbox for assessment of prodromal Alzheimer's disease and dementia
por: Hackett, Katherine, et al.
Publicado: (2018)

Long-Term Retention Deficit Involvement in Prodromal Alzheimer’s Disease
por: Jonin, P. Y., et al.
Publicado: (2010)

Prodromal Alzheimer’s Disease: Constitutive Upregulation of Neuroglobin Prevents the Initiation of Alzheimer’s Pathology
por: de Vidania, Silvia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lcbja8kaasnoi92ses7vjsgm2i